Axon Fell 13% This Week. Here’s Why Investors Are Repricing the Stock Into 2026
Summary
Axon Enterprise shares declined about 13% this week as investors repriced high-growth public-safety tech names and shifted emphasis toward near-term profitability. Insider selling and elevated valuation expectations amplified pressure despite management reporting 33% revenue growth, 46% bookings growth for 2025, and a $14.4 billion bookings backlog. The company highlighted strong adoption of software and AI offerings—including $750M tied to AI under its AI Era Plan—which underpins higher-margin recurring revenue over the long term even as near-term margins face pressure. Institutional activity was mixed, with several firms increasing exposure while others sharply reduced stakes. Valuation models cited in the article still show meaningful implied upside contingent on software adoption, margin expansion, and recurring revenue growth.